Amgen Inc. Cedear (AMGNC)
BCBA
13.82
-0.48 (-3.36%)
Closed
Sep 22, 2026
Day's Range
13.8213.82
52 wk Range
12.6614.30
Overview - AMGNC - Amgen Inc. Cedear
Key Statistics
Trading
Volume
1
Peers - AMGNC - Amgen Inc. Cedear
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- AMGNCBCBAAmgen Inc. Cedear+6.01%52-week change—P/E (Trailing)—Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR+38.30%52-week change11.00P/E (Trailing)‪21.48%‬Profit Margin
- GILDBCBAGilead Sciences Inc.+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.+35.08%52-week change4.90P/E (Trailing)‪18.87%‬Profit Margin
- MRKBCBAMerck & Co., Inc. CEDEAR+51.25%52-week change2.52P/E (Trailing)‪4.76%‬Profit Margin
- LLYBCBAEli Lilly and Company CEDEAR+43.62%52-week change0.19P/E (Trailing)‪33.52%‬Profit Margin
- BIIBBCBABiogen Inc. CEDEAR+43.89%52-week change3.32P/E (Trailing)‪8.32%‬Profit Margin
Profile Summary - AMGNC - Amgen Inc. Cedear
About
Amgen Inc. Cedear represents an interest in Amgen Inc., a global biotechnology company specializing in human therapeutics. The company discovers, develops, manufactures, and delivers innovative biological medicines designed to address serious and often chronic diseases across major therapeutic areas, including…
SectorHealthcare
IndustryDrug Manufacturers - General
Employees31.50K
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
